In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study

Kristian Wachtell; Eva Gerdts; Gerard P Aurigemma; Kurt Boman; Björn Dahlöf; Markku S Nieminen; Michael Hecht Olsen; Peter M Okin; Vittorio Palmieri; Jens E Rokkedal; Richard B Devereux

doi:10.3109/08037051.2010.481811

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study

Kristian Wachtell, Eva Gerdts, Gerard P Aurigemma, Kurt Boman, Björn Dahlöf, Markku S Nieminen, Michael Hecht Olsen, Peter M Okin, Vittorio Palmieri, Jens E Rokkedal, Richard B Devereux

Medicinsk Afdeling GLO

58 Citationer (Scopus)

Abstract

It is unclear whether improvement of left atrial (LA) and ventricular (LV) structure results in reduction in new-onset atrial fibrillation (AF). The aim of the present study was to examine whether changes in-treatment LA diameter were related to changes in risk of new-onset AF.

Originalsprog	Engelsk
Tidsskrift	Blood Pressure
Vol/bind	19
Udgave nummer	3
Sider (fra-til)	169-75
Antal sider	7
ISSN	0803-7051
DOI	https://doi.org/10.3109/08037051.2010.481811
Status	Udgivet - 1 jun. 2010

Adgang til dokumentet

10.3109/08037051.2010.481811

Fingeraftryk

Dyk ned i forskningsemnerne om 'In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Wachtell, K., Gerdts, E., Aurigemma, G. P., Boman, K., Dahlöf, B., Nieminen, M. S., Olsen, M. H., Okin, P. M., Palmieri, V., Rokkedal, J. E., & Devereux, R. B. (2010). In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Blood Pressure, 19(3), 169-75. https://doi.org/10.3109/08037051.2010.481811

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. / Wachtell, Kristian; Gerdts, Eva; Aurigemma, Gerard P et al.
I: Blood Pressure, Bind 19, Nr. 3, 01.06.2010, s. 169-75.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Wachtell, K, Gerdts, E, Aurigemma, GP, Boman, K, Dahlöf, B, Nieminen, MS, Olsen, MH, Okin, PM, Palmieri, V, Rokkedal, JE & Devereux, RB 2010, 'In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study', Blood Pressure, bind 19, nr. 3, s. 169-75. https://doi.org/10.3109/08037051.2010.481811

@article{7879ccbda6764beea6ae9dcad8f40447,

title = "In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study",

abstract = "It is unclear whether improvement of left atrial (LA) and ventricular (LV) structure results in reduction in new-onset atrial fibrillation (AF). The aim of the present study was to examine whether changes in-treatment LA diameter were related to changes in risk of new-onset AF.",

author = "Kristian Wachtell and Eva Gerdts and Aurigemma, {Gerard P} and Kurt Boman and Bj{\"o}rn Dahl{\"o}f and Nieminen, {Markku S} and Olsen, {Michael Hecht} and Okin, {Peter M} and Vittorio Palmieri and Rokkedal, {Jens E} and Devereux, {Richard B}",

year = "2010",

month = jun,

day = "1",

doi = "10.3109/08037051.2010.481811",

language = "English",

volume = "19",

pages = "169--75",

journal = "Blood Pressure",

issn = "0803-7051",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study

AU - Wachtell, Kristian

AU - Gerdts, Eva

AU - Aurigemma, Gerard P

AU - Boman, Kurt

AU - Dahlöf, Björn

AU - Nieminen, Markku S

AU - Olsen, Michael Hecht

AU - Okin, Peter M

AU - Palmieri, Vittorio

AU - Rokkedal, Jens E

AU - Devereux, Richard B

PY - 2010/6/1

Y1 - 2010/6/1

N2 - It is unclear whether improvement of left atrial (LA) and ventricular (LV) structure results in reduction in new-onset atrial fibrillation (AF). The aim of the present study was to examine whether changes in-treatment LA diameter were related to changes in risk of new-onset AF.

AB - It is unclear whether improvement of left atrial (LA) and ventricular (LV) structure results in reduction in new-onset atrial fibrillation (AF). The aim of the present study was to examine whether changes in-treatment LA diameter were related to changes in risk of new-onset AF.

U2 - 10.3109/08037051.2010.481811

DO - 10.3109/08037051.2010.481811

M3 - Journal article

C2 - 20438307

SN - 0803-7051

VL - 19

SP - 169

EP - 175

JO - Blood Pressure

JF - Blood Pressure

IS - 3

ER -